Peru
Diabetes country report 2000 — 2050
Number of adults (20–79 years) with diabetes in Peru (PE)
2000 | 528.4 thousand |
2011 | 942.2 thousand |
2024 | 1.3 million |
2050 | 2.2 million |
Peru is one of the 19 countries and territories in the IDF South and Central America Region.
Data source(s) used for the diabetes estimates in adults:
- Segundo Seclen, Moisés Rosas,Arturo Arias, Ernesto Huayta BMJ Open Diabetes Res Care. 2015 Oct 19;3(1):e000110. doi: 10.1136/bmjdrc-2015-000110. eCollection 2015. PMID: 26512325.
- Stefany Katherine Cerpa-Arana , Lourdes Magaly Rimarachín-Palacios , Antonio Bernabé-Ortiz Rev Saude Publica. 2022 Oct 24:56:91. doi: 10.11606/s1518-8787.2022056004132. eCollection 2022. PMID:36287488
Diabetes estimates (20-79 y) | ||||
---|---|---|---|---|
People with diabetes, in 1,000s | 528.4 | 942.2 | 1,335.8 | 2,155.8 |
Age-standardised prevalence of diabetes, % | - | 6.0 | 6.4 | 7.2 |
Proportion of people with undiagnosed diabetes, % | - | - | 25.5 | - |
People with undiagnosed diabetes, in 1,000s | - | - | 340.9 | - |
Impaired Fasting Glucose (IFG) | ||||
---|---|---|---|---|
People with IFG, in 1,000s | - | - | 1,989.1 | 3,003.6 |
Age-standardised prevalence of IFG, % | - | - | 9.2 | 10.1 |
Impaired Glucose Tolerance (IGT) | ||||
---|---|---|---|---|
People with IGT, in 1,000s | - | 988.5 | 2,308.1 | 3,513.8 |
Age-standardised prevalence of IGT, % | - | 6.0 | 10.7 | 11.8 |
Mortality attributable to diabetes (20-79 y) | ||||
---|---|---|---|---|
Deaths attributable to diabetes | - | 7,010.0 | 7,217.8 | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 6.1 | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
---|---|---|---|---|
Live births affected by HIP | - | - | - | - |
Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - |
Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - |
Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - |
Diabetes-related health expenditure | ||||
---|---|---|---|---|
Total diabetes-related health expenditure, USD million | - | - | 1,880.8 | 2,566.8 |
Total diabetes-related health expenditure, ID million | - | - | 3,906.8 | 5,331.7 |
Diabetes-related health expenditure per person, USD | - | 311.0 | 1,408.0 | 1,190.6 |
Diabetes-related health expenditure per person, ID | - | - | 2,924.7 | 2,473.1 |
Type 1 diabetes estimates in children and adolescents | ||||
---|---|---|---|---|
People with type 1 diabetes (all age groups) | - | - | 19,247.0 | - |
People with type 1 diabetes (0-19 y) | - | - | 4,063.3 | - |
Demographics | ||||
---|---|---|---|---|
Total adult population (20-79 y), in 1,000s | 14,217.0 | 17,503.7 | 22,325.2 | 29,675.0 |
Population of children and adolescents (0-19 y) | - | - | 11,097,623.0 | - |
Diabetes estimates (20-79 y) | |
---|---|
People with diabetes, in 1,000s | 528.4 |
Age-standardised prevalence of diabetes, % | - |
Proportion of people with undiagnosed diabetes, % | - |
People with undiagnosed diabetes, in 1,000s | - |
Impaired Fasting Glucose (IFG) | |
---|---|
People with IFG, in 1,000s | - |
Age-standardised prevalence of IFG, % | - |
Impaired Glucose Tolerance (IGT) | |
---|---|
People with IGT, in 1,000s | - |
Age-standardised prevalence of IGT, % | - |
Mortality attributable to diabetes (20-79 y) | |
---|---|
Deaths attributable to diabetes | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
---|---|
Live births affected by HIP | - |
Prevalence of gestational diabetes mellitus (GDM), % | - |
Live births affected by other types of diabetes first detected in pregnancy | - |
Live births affected by other types of diabetes detected prior to pregnancy | - |
Diabetes-related health expenditure | |
---|---|
Total diabetes-related health expenditure, USD million | - |
Total diabetes-related health expenditure, ID million | - |
Diabetes-related health expenditure per person, USD | - |
Diabetes-related health expenditure per person, ID | - |
Type 1 diabetes estimates in children and adolescents | |
---|---|
People with type 1 diabetes (all age groups) | - |
People with type 1 diabetes (0-19 y) | - |
Demographics | |
---|---|
Total adult population (20-79 y), in 1,000s | 14,217.0 |
Population of children and adolescents (0-19 y) | - |